 | • レポートコード：MRC2-11QY00345 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は凝固XI因子のグローバル市場について調査・分析したレポートです。種類別（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他）市場規模、用途別（血栓症、出血・凝固障害、急性虚血性脳卒中、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別凝固XI因子の競争状況、市場シェア ・世界の凝固XI因子市場：種類別市場規模 2015年-2020年（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他） ・世界の凝固XI因子市場：種類別市場規模予測 2021年-2026年（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他） ・世界の凝固XI因子市場：用途別市場規模 2015年-2020年（血栓症、出血・凝固障害、急性虚血性脳卒中、その他） ・世界の凝固XI因子市場：用途別市場規模予測 2021年-2026年（血栓症、出血・凝固障害、急性虚血性脳卒中、その他） ・北米の凝固XI因子市場分析：米国、カナダ ・ヨーロッパの凝固XI因子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの凝固XI因子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の凝固XI因子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの凝固XI因子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer AG、Bristol-Myers Squibb Company、Cambryn Biologics LLC、eXithera Pharmaceuticals, Inc、Ionis Pharmaceuticals, Inc.、LegoChem Biosciences, Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Coagulation Factor XI Market
The global Coagulation Factor XI market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Coagulation Factor XI Scope and Market Size
Coagulation Factor XI market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Coagulation Factor XI market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Coagulation Factor XI market is segmented into
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Segment by Application, the Coagulation Factor XI market is segmented into
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
Regional and Country-level Analysis
The Coagulation Factor XI market is analysed and market size information is provided by regions (countries).
The key regions covered in the Coagulation Factor XI market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Coagulation Factor XI Market Share Analysis
Coagulation Factor XI market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Coagulation Factor XI business, the date to enter into the Coagulation Factor XI market, Coagulation Factor XI product introduction, recent developments, etc.
The major vendors covered:
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
…
1 Study Coverage
1.1 Coagulation Factor XI Product Introduction
1.2 Market Segments
1.3 Key Coagulation Factor XI Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Coagulation Factor XI Market Size Growth Rate by Type
1.4.2 MR-1007
1.4.3 IONIS-FXIRx
1.4.4 EP-7041
1.4.5 AB-022
1.4.6 BMS-262084
1.4.7 Others
1.5 Market by Application
1.5.1 Global Coagulation Factor XI Market Size Growth Rate by Application
1.5.2 Thrombosis
1.5.3 Bleeding and Clotting Disorders
1.5.4 Acute Ischemic Stroke
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Coagulation Factor XI Market Size, Estimates and Forecasts
2.1.1 Global Coagulation Factor XI Revenue 2015-2026
2.1.2 Global Coagulation Factor XI Sales 2015-2026
2.2 Global Coagulation Factor XI, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Coagulation Factor XI Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Coagulation Factor XI Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Coagulation Factor XI Competitor Landscape by Players
3.1 Coagulation Factor XI Sales by Manufacturers
3.1.1 Coagulation Factor XI Sales by Manufacturers (2015-2020)
3.1.2 Coagulation Factor XI Sales Market Share by Manufacturers (2015-2020)
3.2 Coagulation Factor XI Revenue by Manufacturers
3.2.1 Coagulation Factor XI Revenue by Manufacturers (2015-2020)
3.2.2 Coagulation Factor XI Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Coagulation Factor XI Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Coagulation Factor XI Revenue in 2019
3.2.5 Global Coagulation Factor XI Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Coagulation Factor XI Price by Manufacturers
3.4 Coagulation Factor XI Manufacturing Base Distribution, Product Types
3.4.1 Coagulation Factor XI Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Coagulation Factor XI Product Type
3.4.3 Date of International Manufacturers Enter into Coagulation Factor XI Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Coagulation Factor XI Market Size by Type (2015-2020)
4.1.1 Global Coagulation Factor XI Sales by Type (2015-2020)
4.1.2 Global Coagulation Factor XI Revenue by Type (2015-2020)
4.1.3 Coagulation Factor XI Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Coagulation Factor XI Market Size Forecast by Type (2021-2026)
4.2.1 Global Coagulation Factor XI Sales Forecast by Type (2021-2026)
4.2.2 Global Coagulation Factor XI Revenue Forecast by Type (2021-2026)
4.2.3 Coagulation Factor XI Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Coagulation Factor XI Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Coagulation Factor XI Market Size by Application (2015-2020)
5.1.1 Global Coagulation Factor XI Sales by Application (2015-2020)
5.1.2 Global Coagulation Factor XI Revenue by Application (2015-2020)
5.1.3 Coagulation Factor XI Price by Application (2015-2020)
5.2 Coagulation Factor XI Market Size Forecast by Application (2021-2026)
5.2.1 Global Coagulation Factor XI Sales Forecast by Application (2021-2026)
5.2.2 Global Coagulation Factor XI Revenue Forecast by Application (2021-2026)
5.2.3 Global Coagulation Factor XI Price Forecast by Application (2021-2026)
6 North America
6.1 North America Coagulation Factor XI by Country
6.1.1 North America Coagulation Factor XI Sales by Country
6.1.2 North America Coagulation Factor XI Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Coagulation Factor XI Market Facts & Figures by Type
6.3 North America Coagulation Factor XI Market Facts & Figures by Application
7 Europe
7.1 Europe Coagulation Factor XI by Country
7.1.1 Europe Coagulation Factor XI Sales by Country
7.1.2 Europe Coagulation Factor XI Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Coagulation Factor XI Market Facts & Figures by Type
7.3 Europe Coagulation Factor XI Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Coagulation Factor XI by Region
8.1.1 Asia Pacific Coagulation Factor XI Sales by Region
8.1.2 Asia Pacific Coagulation Factor XI Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Coagulation Factor XI Market Facts & Figures by Type
8.3 Asia Pacific Coagulation Factor XI Market Facts & Figures by Application
9 Latin America
9.1 Latin America Coagulation Factor XI by Country
9.1.1 Latin America Coagulation Factor XI Sales by Country
9.1.2 Latin America Coagulation Factor XI Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Coagulation Factor XI Market Facts & Figures by Type
9.3 Central & South America Coagulation Factor XI Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Coagulation Factor XI by Country
10.1.1 Middle East and Africa Coagulation Factor XI Sales by Country
10.1.2 Middle East and Africa Coagulation Factor XI Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Coagulation Factor XI Market Facts & Figures by Type
10.3 Middle East and Africa Coagulation Factor XI Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Coagulation Factor XI Products Offered
11.1.5 Bayer AG Related Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Description and Business Overview
11.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Company Coagulation Factor XI Products Offered
11.2.5 Bristol-Myers Squibb Company Related Developments
11.3 Cambryn Biologics LLC
11.3.1 Cambryn Biologics LLC Corporation Information
11.3.2 Cambryn Biologics LLC Description and Business Overview
11.3.3 Cambryn Biologics LLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cambryn Biologics LLC Coagulation Factor XI Products Offered
11.3.5 Cambryn Biologics LLC Related Developments
11.4 eXithera Pharmaceuticals, Inc
11.4.1 eXithera Pharmaceuticals, Inc Corporation Information
11.4.2 eXithera Pharmaceuticals, Inc Description and Business Overview
11.4.3 eXithera Pharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Products Offered
11.4.5 eXithera Pharmaceuticals, Inc Related Developments
11.5 Ionis Pharmaceuticals, Inc.
11.5.1 Ionis Pharmaceuticals, Inc. Corporation Information
11.5.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
11.5.3 Ionis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Products Offered
11.5.5 Ionis Pharmaceuticals, Inc. Related Developments
11.6 LegoChem Biosciences, Inc
11.6.1 LegoChem Biosciences, Inc Corporation Information
11.6.2 LegoChem Biosciences, Inc Description and Business Overview
11.6.3 LegoChem Biosciences, Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 LegoChem Biosciences, Inc Coagulation Factor XI Products Offered
11.6.5 LegoChem Biosciences, Inc Related Developments
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Coagulation Factor XI Products Offered
11.1.5 Bayer AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Coagulation Factor XI Market Estimates and Projections by Region
12.1.1 Global Coagulation Factor XI Sales Forecast by Regions 2021-2026
12.1.2 Global Coagulation Factor XI Revenue Forecast by Regions 2021-2026
12.2 North America Coagulation Factor XI Market Size Forecast (2021-2026)
12.2.1 North America: Coagulation Factor XI Sales Forecast (2021-2026)
12.2.2 North America: Coagulation Factor XI Revenue Forecast (2021-2026)
12.2.3 North America: Coagulation Factor XI Market Size Forecast by Country (2021-2026)
12.3 Europe Coagulation Factor XI Market Size Forecast (2021-2026)
12.3.1 Europe: Coagulation Factor XI Sales Forecast (2021-2026)
12.3.2 Europe: Coagulation Factor XI Revenue Forecast (2021-2026)
12.3.3 Europe: Coagulation Factor XI Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Coagulation Factor XI Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Coagulation Factor XI Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Coagulation Factor XI Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Coagulation Factor XI Market Size Forecast by Region (2021-2026)
12.5 Latin America Coagulation Factor XI Market Size Forecast (2021-2026)
12.5.1 Latin America: Coagulation Factor XI Sales Forecast (2021-2026)
12.5.2 Latin America: Coagulation Factor XI Revenue Forecast (2021-2026)
12.5.3 Latin America: Coagulation Factor XI Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Coagulation Factor XI Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Coagulation Factor XI Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Coagulation Factor XI Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Coagulation Factor XI Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Coagulation Factor XI Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Coagulation Factor XI Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Coagulation Factor XI Market Segments
Table 2. Ranking of Global Top Coagulation Factor XI Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Coagulation Factor XI Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of MR-1007
Table 5. Major Manufacturers of IONIS-FXIRx
Table 6. Major Manufacturers of EP-7041
Table 7. Major Manufacturers of AB-022
Table 8. Major Manufacturers of BMS-262084
Table 9. Major Manufacturers of Others
Table 10. Global Coagulation Factor XI Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Coagulation Factor XI Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Coagulation Factor XI Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Coagulation Factor XI Sales Market Share by Regions (2015-2020)
Table 14. Global Coagulation Factor XI Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Coagulation Factor XI Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Coagulation Factor XI Sales Share by Manufacturers (2015-2020)
Table 17. Global Coagulation Factor XI Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Coagulation Factor XI by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor XI as of 2019)
Table 19. Coagulation Factor XI Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Coagulation Factor XI Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Coagulation Factor XI Price (2015-2020) (USD/Pcs)
Table 22. Coagulation Factor XI Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Coagulation Factor XI Product Type
Table 24. Date of International Manufacturers Enter into Coagulation Factor XI Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Coagulation Factor XI Sales by Type (2015-2020) (K Pcs)
Table 27. Global Coagulation Factor XI Sales Share by Type (2015-2020)
Table 28. Global Coagulation Factor XI Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Coagulation Factor XI Revenue Share by Type (2015-2020)
Table 30. Coagulation Factor XI Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Coagulation Factor XI Sales by Application (2015-2020) (K Pcs)
Table 32. Global Coagulation Factor XI Sales Share by Application (2015-2020)
Table 33. North America Coagulation Factor XI Sales by Country (2015-2020) (K Pcs)
Table 34. North America Coagulation Factor XI Sales Market Share by Country (2015-2020)
Table 35. North America Coagulation Factor XI Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Coagulation Factor XI Revenue Market Share by Country (2015-2020)
Table 37. North America Coagulation Factor XI Sales by Type (2015-2020) (K Pcs)
Table 38. North America Coagulation Factor XI Sales Market Share by Type (2015-2020)
Table 39. North America Coagulation Factor XI Sales by Application (2015-2020) (K Pcs)
Table 40. North America Coagulation Factor XI Sales Market Share by Application (2015-2020)
Table 41. Europe Coagulation Factor XI Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Coagulation Factor XI Sales Market Share by Country (2015-2020)
Table 43. Europe Coagulation Factor XI Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Coagulation Factor XI Revenue Market Share by Country (2015-2020)
Table 45. Europe Coagulation Factor XI Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Coagulation Factor XI Sales Market Share by Type (2015-2020)
Table 47. Europe Coagulation Factor XI Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Coagulation Factor XI Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Coagulation Factor XI Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Coagulation Factor XI Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Coagulation Factor XI Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Coagulation Factor XI Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Coagulation Factor XI Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Coagulation Factor XI Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Coagulation Factor XI Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Coagulation Factor XI Sales Market Share by Application (2015-2020)
Table 57. Latin America Coagulation Factor XI Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Coagulation Factor XI Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Coagulation Factor XI Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Coagulation Factor XI Revenue Market Share by Country (2015-2020)
Table 61. Latin America Coagulation Factor XI Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Coagulation Factor XI Sales Market Share by Type (2015-2020)
Table 63. Latin America Coagulation Factor XI Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Coagulation Factor XI Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Coagulation Factor XI Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Coagulation Factor XI Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Coagulation Factor XI Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Coagulation Factor XI Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Coagulation Factor XI Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Coagulation Factor XI Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Coagulation Factor XI Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Coagulation Factor XI Sales Market Share by Application (2015-2020)
Table 73. Bayer AG Corporation Information
Table 74. Bayer AG Description and Major Businesses
Table 75. Bayer AG Coagulation Factor XI Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Bayer AG Product
Table 77. Bayer AG Recent Development
Table 78. Bristol-Myers Squibb Company Corporation Information
Table 79. Bristol-Myers Squibb Company Description and Major Businesses
Table 80. Bristol-Myers Squibb Company Coagulation Factor XI Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Bristol-Myers Squibb Company Product
Table 82. Bristol-Myers Squibb Company Recent Development
Table 83. Cambryn Biologics LLC Corporation Information
Table 84. Cambryn Biologics LLC Description and Major Businesses
Table 85. Cambryn Biologics LLC Coagulation Factor XI Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Cambryn Biologics LLC Product
Table 87. Cambryn Biologics LLC Recent Development
Table 88. eXithera Pharmaceuticals, Inc Corporation Information
Table 89. eXithera Pharmaceuticals, Inc Description and Major Businesses
Table 90. eXithera Pharmaceuticals, Inc Coagulation Factor XI Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. eXithera Pharmaceuticals, Inc Product
Table 92. eXithera Pharmaceuticals, Inc Recent Development
Table 93. Ionis Pharmaceuticals, Inc. Corporation Information
Table 94. Ionis Pharmaceuticals, Inc. Description and Major Businesses
Table 95. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Ionis Pharmaceuticals, Inc. Product
Table 97. Ionis Pharmaceuticals, Inc. Recent Development
Table 98. LegoChem Biosciences, Inc Corporation Information
Table 99. LegoChem Biosciences, Inc Description and Major Businesses
Table 100. LegoChem Biosciences, Inc Coagulation Factor XI Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. LegoChem Biosciences, Inc Product
Table 102. LegoChem Biosciences, Inc Recent Development
Table 103. Global Coagulation Factor XI Sales Forecast by Regions (2021-2026) (K Pcs)
Table 104. Global Coagulation Factor XI Sales Market Share Forecast by Regions (2021-2026)
Table 105. Global Coagulation Factor XI Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 106. Global Coagulation Factor XI Revenue Market Share Forecast by Regions (2021-2026)
Table 107. North America: Coagulation Factor XI Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. North America: Coagulation Factor XI Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Europe: Coagulation Factor XI Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Europe: Coagulation Factor XI Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Asia Pacific: Coagulation Factor XI Sales Forecast by Region (2021-2026) (K Pcs)
Table 112. Asia Pacific: Coagulation Factor XI Revenue Forecast by Region (2021-2026) (US$ Million)
Table 113. Latin America: Coagulation Factor XI Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Latin America: Coagulation Factor XI Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Middle East and Africa: Coagulation Factor XI Sales Forecast by Country (2021-2026) (K Pcs)
Table 116. Middle East and Africa: Coagulation Factor XI Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 118. Key Challenges
Table 119. Market Risks
Table 120. Main Points Interviewed from Key Coagulation Factor XI Players
Table 121. Coagulation Factor XI Customers List
Table 122. Coagulation Factor XI Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Coagulation Factor XI Product Picture
Figure 2. Global Coagulation Factor XI Sales Market Share by Type in 2020 & 2026
Figure 3. MR-1007 Product Picture
Figure 4. IONIS-FXIRx Product Picture
Figure 5. EP-7041 Product Picture
Figure 6. AB-022 Product Picture
Figure 7. BMS-262084 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Coagulation Factor XI Sales Market Share by Application in 2020 & 2026
Figure 10. Thrombosis
Figure 11. Bleeding and Clotting Disorders
Figure 12. Acute Ischemic Stroke
Figure 13. Others
Figure 14. Coagulation Factor XI Report Years Considered
Figure 15. Global Coagulation Factor XI Market Size 2015-2026 (US$ Million)
Figure 16. Global Coagulation Factor XI Sales 2015-2026 (K Pcs)
Figure 17. Global Coagulation Factor XI Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Coagulation Factor XI Sales Market Share by Region (2015-2020)
Figure 19. Global Coagulation Factor XI Sales Market Share by Region in 2019
Figure 20. Global Coagulation Factor XI Revenue Market Share by Region (2015-2020)
Figure 21. Global Coagulation Factor XI Revenue Market Share by Region in 2019
Figure 22. Global Coagulation Factor XI Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Coagulation Factor XI Revenue in 2019
Figure 24. Coagulation Factor XI Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Coagulation Factor XI Sales Market Share by Type (2015-2020)
Figure 26. Global Coagulation Factor XI Sales Market Share by Type in 2019
Figure 27. Global Coagulation Factor XI Revenue Market Share by Type (2015-2020)
Figure 28. Global Coagulation Factor XI Revenue Market Share by Type in 2019
Figure 29. Global Coagulation Factor XI Market Share by Price Range (2015-2020)
Figure 30. Global Coagulation Factor XI Sales Market Share by Application (2015-2020)
Figure 31. Global Coagulation Factor XI Sales Market Share by Application in 2019
Figure 32. Global Coagulation Factor XI Revenue Market Share by Application (2015-2020)
Figure 33. Global Coagulation Factor XI Revenue Market Share by Application in 2019
Figure 34. North America Coagulation Factor XI Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Coagulation Factor XI Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Coagulation Factor XI Sales Market Share by Country in 2019
Figure 37. North America Coagulation Factor XI Revenue Market Share by Country in 2019
Figure 38. U.S. Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Coagulation Factor XI Market Share by Type in 2019
Figure 43. North America Coagulation Factor XI Market Share by Application in 2019
Figure 44. Europe Coagulation Factor XI Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Coagulation Factor XI Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Coagulation Factor XI Sales Market Share by Country in 2019
Figure 47. Europe Coagulation Factor XI Revenue Market Share by Country in 2019
Figure 48. Germany Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Coagulation Factor XI Market Share by Type in 2019
Figure 59. Europe Coagulation Factor XI Market Share by Application in 2019
Figure 60. Asia Pacific Coagulation Factor XI Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Coagulation Factor XI Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Coagulation Factor XI Sales Market Share by Region in 2019
Figure 63. Asia Pacific Coagulation Factor XI Revenue Market Share by Region in 2019
Figure 64. China Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Coagulation Factor XI Market Share by Type in 2019
Figure 87. Asia Pacific Coagulation Factor XI Market Share by Application in 2019
Figure 88. Latin America Coagulation Factor XI Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Coagulation Factor XI Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Coagulation Factor XI Sales Market Share by Country in 2019
Figure 91. Latin America Coagulation Factor XI Revenue Market Share by Country in 2019
Figure 92. Mexico Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Coagulation Factor XI Market Share by Type in 2019
Figure 99. Latin America Coagulation Factor XI Market Share by Application in 2019
Figure 100. Middle East and Africa Coagulation Factor XI Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Coagulation Factor XI Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Coagulation Factor XI Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Coagulation Factor XI Revenue Market Share by Country in 2019
Figure 104. Turkey Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Coagulation Factor XI Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Coagulation Factor XI Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Coagulation Factor XI Market Share by Type in 2019
Figure 111. Middle East and Africa Coagulation Factor XI Market Share by Application in 2019
Figure 112. North America Coagulation Factor XI Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Coagulation Factor XI Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Coagulation Factor XI Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Coagulation Factor XI Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Coagulation Factor XI Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Coagulation Factor XI Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Coagulation Factor XI Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Coagulation Factor XI Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Coagulation Factor XI Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Coagulation Factor XI Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
ヒト凝固因子IXの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IX Market The global Human Coagulation Factor IX market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IX Scope and Market Size Human Coa…- ヒト凝固因子IVの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IV Market The global Human Coagulation Factor IV market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IV Scope and Market Size Human Coa…
- 凝固因子濃縮物の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor Concentrates Market The global Coagulation Factor Concentrates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor Concentrates Scope and Market Si…
- 組換え凝固因子の世界市場（～2026年） Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents. Market Analysis and Insights: Global Recomb…
- 出血性疾患の世界市場（～2026年） The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand. Market Analysis and Insights: Global Bleeding Disorders Market The global Bleeding Disorders mark…